Metformin Plus Insulin Therapy Does Not Reduce Neonatal Adverse Outcomes
Metformin plus insulin therapy vs placebo was not associated with reduced neonatal adverse outcomes among type 2 and gestational diabetes patients.
Source: endocrinologyadvisor.com